Neuronetics (STIM) Operating Income (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.37% |
| Dec 31, 2025 | 31.12% |
| Sep 30, 2025 | 9.15% |
| Jun 30, 2025 | 26.84% |
| Mar 31, 2025 | 3.99% |
| Dec 31, 2024 | -48.45% |
| Sep 30, 2024 | 9.16% |
| Jun 30, 2024 | -24.03% |
| Mar 31, 2024 | -54.94% |
| Dec 31, 2023 | 50.10% |
| Sep 30, 2023 | -20.71% |
| Jun 30, 2023 | 25.82% |
| Mar 31, 2023 | -28.21% |
| Dec 31, 2022 | -3.66% |
| Sep 30, 2022 | 23.91% |
| Jun 30, 2022 | 3.34% |
| Mar 31, 2022 | -46.69% |
| Dec 31, 2021 | 3.80% |
| Sep 30, 2021 | -9.41% |
| Jun 30, 2021 | 4.99% |
| Mar 31, 2021 | -159.74% |
| Dec 31, 2020 | -9.74% |
| Sep 30, 2020 | 64.66% |
| Jun 30, 2020 | 33.83% |
| Mar 31, 2020 | -49.39% |
| Dec 31, 2019 | -9.66% |
| Sep 30, 2019 | 4.22% |
| Jun 30, 2019 | 6.36% |
| Mar 31, 2019 | -24.64% |
| Dec 31, 2018 | -30.68% |
| Sep 30, 2018 | 17.27% |
| Jun 30, 2018 | -13.70% |
| Mar 31, 2018 | -8.79% |
| Dec 31, 2017 | -50.64% |
| Sep 30, 2017 | -9.04% |
| Jun 30, 2017 | 35.38% |